Market Insight - The promise of lipidomics
This article was originally published in Scrip
Executive Summary
A new translational research project launched by the EU looks set to bring the science of lipidomics more into the mainstream of drug discovery and diagnostics in Europe. The project's sponsors expect it to help in the development of new drugs against major diseases where lipids play a significant role, such as diabetes, cancer, stroke and heart disease.